| Filed On | Filing |
|---|---|
| 11 Jun 2026 |
Form 4: Shiff Susan Ph.D., Director
Granted 6,000 Stock Option (right to buy) |
| 11 Jun 2026 |
Form 4: Smith Cynthia, Director
Granted 6,000 Stock Option (right to buy) |
| 11 Jun 2026 |
Form 4: Shah Sujal, Director
Granted 6,000 Stock Option (right to buy) |
| 11 Jun 2026 |
Form 4: Hall Wallace L Jr, Director
Granted 6,000 Stock Option (right to buy) |
| 11 Jun 2026 |
Form 4: Wyzga Michael S, Director
Granted 6,000 Stock Option (right to buy) |
| 02 Feb 2026 |
Form 4: O'Brien Stephen Paul, Principal Accounting Officer
Granted 15,000 Employee Stock Option (right to buy) |
| 02 Feb 2026 |
Form 4: Conn Avi Daniel, Chief Financial Officer
Granted 45,000 Employee Stock Option (right to buy) |
| 02 Feb 2026 |
Form 4: Alibhai Imran Nizamudin, Director
Granted 115,000 Employee Stock Option (right to buy) |
| 02 Feb 2026 |
Form 4: Kauh John Saewook M.d., Chief Medical Officer
Granted 45,000 Employee Stock Option (right to buy) |
| 18 Dec 2025 |
Form 4: O'Brien Stephen Paul, Principal Accounting Officer
Granted 4,000 Employee Stock Option (right to buy) |
| 18 Dec 2025 |
Form 4: Kauh John Saewook M.d., Chief Medical Officer
Granted 17,500 Employee Stock Option (right to buy) |
| 18 Dec 2025 |
Form 4: Conn Avi Daniel, Chief Financial Officer
Granted 17,500 Employee Stock Option (right to buy) |
| 18 Dec 2025 |
Form 4: Alibhai Imran Nizamudin, Director
Granted 47,500 Employee Stock Option (right to buy) |
| 05 Aug 2025 |
Form 4: Tweardy Samuel David, 10% owner
Disposed of 631,316 shares (Other Transaction) |
| 21 Apr 2025 |
Form 4: Larson Jeffrey Leroy, SVP, Research & Development
Granted 10,820 Employee Stock Option (right to buy) |
| 21 Apr 2025 |
Form 4: O'Brien Stephen Paul, Principal Accounting Officer
Granted 7,213 Employee Stock Option (right to buy) |
| 21 Apr 2025 |
Form 4: Chen Yixin, VP, Chem, Mfg and Ctrls
Granted 7,213 Employee Stock Option (right to buy) |
| 21 Apr 2025 |
Form 4: Conn Avi Daniel, Chief Financial Officer
Granted 43,547 Employee Stock Option (right to buy) |
| 21 Apr 2025 |
Form 4: Kauh John Saewook M.d., Chief Medical Officer
Granted 36,210 Employee Stock Option (right to buy) |
| 21 Apr 2025 |
Form 4: Alibhai Imran Nizamudin, Director
Granted 182,320 Employee Stock Option (right to buy) |
Loading...